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Abstract
Numerous studies have divided blood monocytes according to their expression of the surface markers CD14 and CD16 into
following subsets: classical CD14++CD162, intermediate CD14++CD16+ and nonclassical CD14+CD16++ monocytes. These
subsets differ in phenotype and function and are further correlated to cardiovascular disease, inflammation and cancer.
However, the CD14/CD16 nature of resident monocytes in human bone marrow remains largely unknown. In the present
study, we identified a major population of CD14++CD16+ monocytes by using cryopreserved bone marrow mononuclear
cells from healthy donors. These cells express essential monocyte-related antigens and chemokine receptors such as CD11a,
CD18, CD44, HLA-DR, Ccr2, Ccr5, Cx3cr1, Cxcr2 and Cxcr4. Notably, the expression of Ccr2 was inducible during culture.
Furthermore, sorted CD14++CD16+ bone marrow cells show typical macrophage morphology, phagocytic activity,
angiogenic features and generation of intracellular oxygen species. Side-by-side comparison of the chemokine receptor
profile with unpaired blood samples also demonstrated that these rather premature medullar monocytes mainly match the
phenotype of intermediate and partially of (non)classical monocytes. Together, human monocytes obviously acquire their
definitive CD14/CD16 signature in the bloodstream and the medullar monocytes probably transform into CD14++CD162
and CD14+CD16++ subsets which appear enriched in the periphery.
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Introduction
Current knowledge defines three major monocyte subsets in
human peripheral blood based on the expression patterns of CD16
(FccRIII) and the LPS-receptor CD14: classical CD14++CD162,
intermediate CD14++CD16+ and nonclassical CD14+CD16++
monocytes [1]. These subsets differ essentially in their chemokine
receptor expression, phagocytic activity and tissue distribution
during inflammation or steady-state conditions [2]. Hence, the
monocyte subsets are differentially involved in the pathophysiology
of inflammation, atherosclerosis and regeneration after injury [3–
5]. In particular, the unique features of the intermediate in
contrast to the nonclassical subset (both previously referred as
CD16+ monocytes) has become recently more evident and
especially in cardiovascular disease this subset was shown to
predict independently cardiovascular events at follow-up [6–8].
Thus, human monocyte subsets may represent a novel prognostic
marker or therapeutic targets in clinical medicine and detailed
investigation of their characteristics in bone marrow (BM) as
compared to peripheral blood appears important for better
understanding of the subset-specific development, maturation
and functional specialization. However, the experimental research
on resident human monocytes in BM together with the plasticity of
subset development and trafficking to the periphery is highly
restricted and only few published data exist. Therefore the aim of
our study is to provide novel evidence on medullar CD14/CD16
monocytes by using commercially available cryopreserved BM
samples from healthy donors as an alternative to fresh BM and to
reveal further the effects of freezing/thawing on monocyte
number, function and chemokine receptor expression.
Materials and Methods
Cells
Cryopreserved bone marrow mononuclear cells (BMCs;
256106 or 1006106) from ten healthy single donors were obtained
by Lonza (Cologne, Germany). The BMCs were thawed and
maintained overnight prior all further experiments in Iscove’s
Modified Dulbecco’s Medium (IMDM; PAA, Pasching, Austria)
supplemented with 10% FCS and antibiotics in 24-well plates
(16106 cells per well). After written informed consent was
obtained, 20 ml of citrate anticoagulated peripheral blood were
collected by aseptic venipuncture from ten healthy volunteers. The
procedure was approved by the Ethics Committee of the Medical
Faculty of the LMU Munich. PBMCs were separated by Biocoll
(Biochrom AG, Berlin, Germany) density gradient centrifugation.
Some fresh PBMCs were immediately analyzed by flow cytometry
as described below while the remaining cells were frozen in RPMI
1640 medium (PAA) with 10% FCS and 5% dimethyl sulfoxide
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(DMSO; Sigma-Aldrich, Taufkirchen, Germany). The cells were
cooled to 280uC in a CoolCell Freezing Container (BioCision, Mill
Valley, CA) before being transferred to liquid nitrogen for storage.
The cryopreserved PBMCs were thawed/cultured after one week
of storage in the same fashion as the BMCs.
Flow cytometry analysis of surface antigens
Cells were collected by thorough resuspension and the flow
cytometry analysis was performed as 4-color experiment by using
the Lyoplate Screening Panel (BD, Heidelberg, Germany)
following staining with anti-human CD45-PerCP (clone 2D1;
BD), CD14-FITC (clone HCD14) and CD16-PE (clone 3G8)
mAbs (both Biolegend, Fell, Germany). The control tube included
anti-human CD45/CD14/CD16 mAbs and the AlexaFluor 647-
conjugated secondary Ab of the screening panel. Further anti-
human mAbs used for multicolor flow cytometry were as follows:
CD117-APC (clone 104D2), CD16-Pacific Blue (clone 3G8),
Ccr2-APC mouse IgG2a (clone K036C2, 100 mg/ml), Ccr5-
AlexaFluor 647 rat IgG2a (clone HEK/1/85a, 100 mg/ml),
Cx3cr1-AlexaFluor 647 rat IgG2b (clone 2A9-1, 100 mg/ml),
Cxcr2-PE mouse IgG1 (clone 5E8, 50 mg/ml), Cxcr4-PE mouse
IgG2a (clone 12G5, 50 mg/ml; all Biolegend); CD15-eFluor450
(clone HI98) and CD56-APC (clone MEM188; both eBioscience,
Vienna, Austria); Tie2-APC (clone 83715; R&D Systems,
Wiesbaden, Germany). Matching fluorescent isotype control Abs
(clones MOPC-21/173 and RTK2758/4530; Biolegend) were
used at same concentration as the respective mAb. Sample tubes
were acquired on a FACSCanto II with Diva v8.0 software (BD)
and appropriate CS&T bead calibration setting. The fluorescence
compensation was automatically calculated using OneComp
eBeads (eBioscience). At least 10.000 events were recorded within
the target population. The specific mean fluorescence intensity
(MFI) was assessed by subtracting the background of the respective
isotype control. To determine chemokine receptor expression over
time some BMCs were cultured in RPMI 1640 medium with 10%
FCS and antibiotics on 6-well plates (46106 cells per well). The
flow cytometry analysis for expression of CD45, CD14, CD16,
Ccr2, Ccr5 and Cx3cr1 was performed after one and seven days of
culture as described above.
Functional assays
Single-donor BMCs (107) or pooled BMCs (756106) of three
individual donors were sorted (FACSAria III; BD) after staining
for CD14/CD16/CD45 and plated on 24-well plates or 4-well
chamber slides in RPMI 1640 medium with 10% FCS and
antibiotics. Phagocytosis of FITC-conjugated latex beads (1:1000;
Sigma-Aldrich) and hydroethidine (10 mg/ml; Invitrogen, Darm-
stadt, Germany) staining for spontaneous intracellular superoxide
production in PBMC- or sorted BMC-derived macrophages were
determined by flow cytometry after 24 hours in culture. Cytoskel-
etal filaments in cultured BMCs were visualized by fluorescence
microscopy (Leica DM6000B, Wetzlar, Germany) after cell
fixation/permeabilization (Cytofix/Cytoperm; BD) following incu-
bation with anti-a-tubulin-FITC (Sigma-Aldrich) mAb and
rhodamine-phalloidin (Biotium, Hayward, CA). Vectashield with
DAPI (Vector Laboratories, Peterborough, UK) was used as
mounting medium and to stain cell nuclei. In another experimen-
tal setup the sorted BMCs were cultured in angiogenesis m-slide
(IBIDI, Martinsried, Germany) on Matrigel (BD) supplemented
with 50 ng/ml VEGF and 100 ng/ml Cxcl12 (both from
Peprotech, Hamburg, Germany).
Statistics
Data were analyzed using Prism 5 software (GraphPad Inc., La
Jolla, CA) and presented as mean6SD. Data distribution was
assessed by the Shapiro-Wilk normality test. Accordingly, we have
used for comparison between two groups the unpaired t test or
nonparametric Mann-Whitney test and for comparison between
three groups one-way ANOVA with Newman-Keuls post-test.
Differences with p,0.05 were considered statistically significant.
Results
Flow cytometry analysis of thawed human BMCs after staining
for CD14, CD16 and CD45 showed clear separation of two scatter
populations (Fig. 1A): a larger CD14++ population (Q1:
17.663.0% of CD45+ cells) with low-to-intermediate expression
of CD16 (CD16+) and a smaller CD142CD16++ population (Q4:
6.161.6% of CD45+ cells). The CD142CD16++ cells in Q4 were
also CD152CD56++ thus probably referring to NK and NK-T
cells (data not shown).
Further analysis of the CD14++CD16+ population revealed
expression of CD11a, CD18, CD44 and HLA-DR together with
other essential monocyte-related antigens (Fig. 1B;S1). There was
also expression of the chemokine receptors Ccr2, Ccr5, Cx3cr1,
Cxcr2 and Cxcr4 as shown in Fig. 1C. Moreover, the expression
of Ccr2 on medullar macrophages was significantly up-regulated
after 7 days in culture (Table 1).
Figure 1. Characterization of CD14++CD16+ bone marrow monocytes by flow cytometry. (A) Representative contour plot of pooled BMC
sample from three single donors showing a clear separation of two populations: CD14++CD16+ (Q1) and CD142CD16++ (Q4). Gating was performed
first in FSC/SSC dot plot following gating on CD45+ events in a SSC/CD45 dot plot. Finally, the expression of CD14 and CD16 was evaluated inside the
CD45+ population. (B,C) Expression of monocyte-related antigens and representative histogram overlays with isotype control (gray filled) of crucial
chemokine receptors on CD14++CD16+ BMCs as analyzed by flow cytometry. Data are from 3 to 6 individual donors.
doi:10.1371/journal.pone.0112140.g001
Table 1. Chemokine receptor expression on cultured medullar macrophages from six single donors as analyzed by flow
cytometry.
Receptor 1 day 7 days p-value
Ccr2 97629% 3516192% 0.04
Ccr5 152631% 3406136% 0.06
Cx3cr1 113641% 3286159% 0.06
The MFI values of CD14++CD16+ monocytes before plating served as control ( = 100%).
doi:10.1371/journal.pone.0112140.t001
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Side-by-side examination of chemokine receptor expression on
CD14++CD16+ BM monocytes versus unpaired cryopreserved
blood samples showed very similar levels for Ccr2, Ccr5 and
Cx3cr1 as compared to intermediate monocytes together with
almost identical levels of Ccr2 on classical and Cx3cr1 on
nonclassical monocytes (Fig. 2A–C; Table S1). Further compar-
ison with unpaired fresh blood monocytes revealed identical
expression of Cx3cr1 as to the nonclassical subset (Fig. 2C).
Overall, the BM monocytes showed highest levels for Cxcr4
(Fig. 2A–C) and more than 206 higher expression of the
hematopoietic precursor marker CD117 (data not shown) whereas
fresh classical monocytes had highest levels of Cxcr2 and Ccr2
(Fig. 2A–C). Another analysis of paired fresh versus cryopreserved
blood monocytes demonstrated significant decrease of Cxcr2 next
to increased expression of Cxcr4, Ccr5 and Cx3cr1 on classical
monocytes while thawed nonclassical monocytes had higher
expression only of Ccr2 as compared to freshly processed cells
(Fig. 2A,C). Finally, cryopreservation failed to affect the percent-
ages of all blood monocyte subsets (Table 2).
Functional analysis demonstrated phagocytic activity by
58.8619.9% of sorted CD14++CD16+ BMCs as well as sponta-
neous generation of reactive oxygen species (ROS) at 61.568.9%
after 24 hours in culture (Fig. 3A,D). By comparison, macrophag-
es originating from frozen PBMCs showed phagocytic capacity of
51.769.5% and spontaneous superoxide production at
41.967.5% (Fig. 3B,E) while freshly isolated macrophages re-
vealed 70.768.1% of bead uptake and 18.062.3% of ROS
production after 24 hours of culture (Fig. 3C,F). Microscopic
immunofluorescence analysis of cultured CD14++CD16+ BMCs
further confirmed typical fried egg-like macrophage morphology
with a-tubulin/F-actin-rich protrusions (Fig. 3G,H). The
CD14++CD16+ BMCs displayed also angiogenic properties as
they express CD31, Tie2 and Cxcr4, and fuse to clusters with
shape change in Matrigel (Fig. 1B,C;3I).
Discussion
To our best knowledge, this is the first study characterizing
CD14/CD16 monocyte subsets in cryopreserved human BM of
healthy donors as a possible alternative to freshly prepared cells.
We found a major pool of CD14++CD16+ BMCs that seems to
correspond to intermediate blood monocytes. These cells clearly
feature monocytes/macrophages as illustrated by their phenotype
and function. Another important analysis mapped the effect of
freezing/thawing on chemokine receptor expression, subset
proportion and function of bloodstream monocytes. A limitation
of our study is the lack of direct validation and comparison with
fresh marrow samples, ideally obtained from the same donor.
However, in contrast to venous blood it is not conceivable to
collect routinely fresh BM of healthy volunteers for experimental
research. Consequently, only one prior work has evaluated the
immunophenotype of monocyte subsets in BM aspirates originat-
Figure 2. Side-by-side comparison of chemokine receptor
expression on medullar with frozen or fresh blood monocytes.
PBMCs from different donors were separated by density gradient
centrifugation. Chemokine receptor expression was analyzed and
compared on fresh monocyte subsets (gray bars) versus cryopreserved
cells of the same donor (open bars) or unpaired medullar monocytes
(black bars). *p,0.05, n = 6–10.
doi:10.1371/journal.pone.0112140.g002
Table 2. Percentages of blood monocyte subsets before and after freezing/thawing (n = 7–10).
Subset fresh thawed p-value
CD14++CD162 80.167.0% 82.863.0% 0.54
CD14++CD16+ 3.762.0% 3.861.5% 0.96
CD14+CD16++ 6.262.8% 6.361.7% 0.93
doi:10.1371/journal.pone.0112140.t002
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ing from healthy individuals with suspected peripheral lymphomas
up to now [9].
Compared to humans, the recruitment of mouse monocyte
subsets in vivo was investigated in detail by using several models of
receptor knock-out, BM transplantation, cell depletion or adoptive
transfer [10–12]. Up to now, there are two major murine
monocyte subsets: the Gr1+/Ly6Chi cells are similar to human
CD14++CD162 monocytes and Gr12/Ly6Clow cells are consid-
ered as counterparts of the CD14+CD16++ monocytes [3,10,11].
During egress from BM, the CC-chemokine Ccl2 (MCP-1) plays a
central role by either inducing Ccr2-dependent chemokinesis or
chemotaxis of Ccr2+Ly6Chi mouse monocytes [11]. Our data
demonstrated comparable expression levels of Ccr2 between
medullar and thawed CD14++ blood monocytes. Remarkably, we
found higher amount of Cxcr4 on BM monocytes in comparison
with frozen or fresh bloodstream monocytes. As human
CD14++CD16+ BMCs express also the adhesion molecule CD44
they may be accessorily attracted by ligands for CD44 and Cxcr4
such as glycosaminoglycans and Cxcl12 to move towards the
vascular niche of the BM and to enter the bloodstream. According
to their origin BM monocytes still express the precursor marker
CD117 which was absent on their terminally differentiated
counterparts in the bloodstream. Further analysis of chemokine
receptors revealed very similar expression profile between
medullar and frozen intermediate monocytes. Fresh classical
monocytes showed highest levels of Ccr2 while the expression of
Cx3cr1 was similar between medullar and CD16++ blood subsets
(fresh or frozen). Of note, the expression of Ccr2 on BMC-derived
macrophages was inducible in culture. Thus, human monocytes
probably acquire their differential chemokine receptor signature
(e.g. high levels of Ccr2 on the classical subset) during or after
recruitment to the periphery with simultaneous decline of Cxcr4
and CD117 in terms of differentiation. It is well conceivable that
such maturation may occur more rapid in vivo than in vitro,
especially during inflammatory conditions or infection with
accompanying monocytosis and preferential shift of classical
monocytes.
Our results next reveal higher expression of some chemokine
receptors on blood monocytes shortly after thawing while the ratio
of receptor expression together with subset frequencies remains
unaffected as compared to fresh monocytes. Accordingly, cryo-
preservation may affect at least transiently the corresponding
chemokine receptors on BMCs as well. Furthermore, macrophag-
es that originated from frozen blood or BM monocytes showed
Figure 3. Functional analyses of CD14++CD16+ BMC- and PBMC-derived macrophages. Representative flow cytometry histogram overlays
for uptake of FITC-conjugated beads (A–C) and hydroethidine staining (D–F) in macrophages cultured from CD14++CD16+ BMCs, fresh or
cryopreserved PBMCs of three single donors. The gray filled histogram shows cells without beads or dye, respectively. (G,H) Phase contrast and
immunofluorescent overlay of CD14++CD16+ BMC-derived macrophages which were cultured in chamber slides and stained for a-tubulin-FITC/
rhodamine-phalloidin after 7 days as described in methods. Cell nuclei were counterstained with DAPI. The scale bar indicates 40 mm. (I) Cluster
formation and shape change of CD14++CD16+ BM cells on Matrigel after 72 hours. Data in (G–I) are representative images of triplicates from pooled
sample of three independent donors.
doi:10.1371/journal.pone.0112140.g003
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similar phagocytic capacity but had significantly increased ROS
production as compared to freshly obtained blood macrophages.
One possible explanation for this difference could be transient cell
activation following cryopreservation. In line with our findings
previous studies have already reported that cryopreservation can
rather influence activation status than frequency or function of
mononuclear cells. In particular, human T-cells, monocytes or
circulating angiogenic cells can be thawed without considerable
alteration of their phenotype and function [13–15]. Cryopreser-
vation is also routinely used for storage of autologous CD34+ cells
suggesting that cryopreserved blood cells usually match fine fresh
cells [16]. Hereby, even if the cryopreserved cells in our study were
not fully equal in phenotype and ROS generation to fresh cells (at
least shortly after thawing) they may represent another alternative
in terms of availability, storage, transportation and functionality.
Surprisingly, we also found that nonclassical monocytes do not
certainly persist as population with clear CD14/CD16 boundaries
among thawed BMCs. As mentioned above it is rather unlike that
cryopreservation per se could impact the abundance of nonclas-
sical monocytes since their proportion remains well-preserved after
freezing/thawing as confirmed also by others [17]. As further
shown in a previous study, the nonclassical monocytes in fresh
marrow samples were not primary identified as separate
CD14+CD16++ scatter population but first on the basis of their
lower Ccr2 expression among gated CD16+ events [9]. Hence, the
proper detection of nonclassical monocytes in BM appears
debatable and may indeed result from ‘‘contamination’’ with
variable amounts of peripheral blood during the BM aspiration.
In contrast to the Ccr2++ classical and intermediate subsets in
the periphery, the nonclassical monocytes are Cx3cr1++ but dimly
express Ccr2 and function mainly as weak phagocytes that patrol
the microvasculature in LFA-1 dependent manner to sense
pathogens or cell remnants at steady-state [18]. Moreover,
nonclassical monocytes express the angiopoietin receptor Tie2
and are further considered as essential paracrine players in tumor
angiogenesis [5,19]. Similar pro-angiogenic characteristics were
recently described for the intermediate subset as well [8]. Since the
CD14++CD16+ BMCs express similar levels of Cx3cr1 and display
pro-angiogenic properties, it seems that nonclassical monocytes
could arise from this mixed population as well but specialize first in
the periphery after coming across pathogens at homeostatic
conditions, e.g. during patrolling the microvasculature of gut and
lung.
In summary, a common CD14++CD16+ monocyte pool
featuring mostly intermediate monocytes is primary enriched in
human BM but depleted in peripheral blood where this subset
exists at lowest percentage. The medullar monocytes seems to
require Ccr2, Cxcr4 and possibly CD44 for mobilization and may
give rise to more specialized peripheral Ccr2++ classical monocytes
with implication during inflammation next to Cx3cr1++ nonclas-
sical monocytes that are rather recruited at steady-state. The
maturation of medullar monocytes obviously associates with
decrease in the expression of Cxcr4 and c-kit. Thus, it is
conceivable that human monocytes acquire their differential
CD14/CD16 signature first in the bloodstream.
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